Yumab GmbH Company Profile, Contacts & Intelligence

Biotechnology ResearchDe24 employeesFounded 2012
2 contacts with email or phone data2 with email data
Employees
24
Company source estimate
Reachable Contacts
2
Visible contacts with email or phone data
Contacts With Email
2
2 of 3 visible contacts
Departments
1
Mapped contact coverage

Yumab GmbH Overview

YUMAB Company profile The German biotech company YUMAB was founded in 2012 as spin-off the University of Braunschweig. In little more than five years, YUMAB (a phonetic play on “HUMAB”, which stands for “human monoclonal antibody and in which the “Y” symbolizes the well-known antibody structure) has become a global player in human monoclonal antibody (mAb) development, and drives the general trend in the immunotherapy space toward the use of fully human mAbs for therapeutic applications. The YUMAB® antibody platform provides rapid, reliable and robust development of “state-of-the-art” and “next-generation” fully human antibodies. The technologies base on more than 28 years of continuous research and development of our founders, who are well recognized scientific experts in the field of recombinant antibody technologies and who have an outstanding track-record in academic and industrial research. YUMAB provides optimized antibody development solutions for: i) discovery & development of novel, fully human antibodies, ii) antibody engineering & humanization, and iii) personalized & custom libraries Key features of the YUMAB® platform are: i) world’s best, naturally derived, universal, human antibody libraries (>10e11) ii) powerful in vitro selection technologies including on-cells-selection for difficult targets iii) large scale screening platforms iv) comprehensive portfolio of antibody engineering & humanization technologies v) compatibility to all therapeutic antibody formats YUMAB provides fee for service solutions with attractive pricing and flexible license models & options as well as collaborative projects. YUMAB’s research & development unit performs internal pipeline and partnered projects ranging from the development of novel antibody therapeutics to the discovery to novel targets technologies. Our mission is to make the best human antibody technologies available for the early development to accelerate translation of research from bench to bedsite.

Headquarters
De
Website
yumab.com
Industry
Biotechnology Research
Founded
2012
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Phone Number
Available in AeroLeads
Company Email
Available in AeroLeads

Yumab GmbH Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

2 contacts with contact data
2 with email data in the visible sample.
1 department represented
Visible contacts with email or phone data are mapped to these departments.
3 company-domain emails
Visible contacts using Yumab GmbH's company email domain.
General
3

Yumab GmbH People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Yumab GmbH Workforce Composition

Seniority breakdown across 13 visible profiles.

Individual contributor
11
Executive
1
Manager
1

Compare Similar Companies to Yumab GmbH

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Rentschler Biopharma Biotechnology Research 871 View company
PROGEN Biotechnology 47 View company
MOLCURE Inc. Biotechnology Research 28 View company
Biofidus AG Biotechnology Research 23 View company
BlueCatBio Biotechnology 21 View company
CORAT Therapeutics GmbH Biotechnology Research 9 View company
Cytion Biotechnology Research 8 View company
inscreenex GmbH Biotechnology 8 View company
Abcalis GmbH Biotechnology Research 7 View company
!LEVA Sciences GmbH Business Consulting And Services 2 View company